As on November 24, 2020, Evogene Ltd. (NASDAQ: EVGN) started slowly as it slid -7.57% to $2.93. During the day, the stock rose to $3.27 and sunk to $2.80 before settling in for the price of $3.17 at the close. Taking a more long-term approach, EVGN posted a 52-week range of $0.75-$5.30.
This publicly-traded company’s shares outstanding now amounts to $35.58 million, simultaneously with a float of $25.96 million. The organization now has a market capitalization sitting at $104.23 million. At the time of writing, stock’s 50-day Moving Average stood at $3.24, while the 200-day Moving Average is $1.74.
Let’s gauge the efficiency of the firm, which has a total of 143 employees. It has generated 18,762 per worker during the last fiscal year. Meanwhile, its income per employee was -451,281. The stock had 0.77 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -312.08, operating margin was -3019.92 and Pretax Margin of -2535.33.
Evogene Ltd. (EVGN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Evogene Ltd.’s current insider ownership accounts for 18.12%, in contrast to 23.96% institutional ownership.
Evogene Ltd. (EVGN) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2017, the company posted -$0.24 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.21) by -$0.03. This company achieved a net margin of -2405.31 while generating a return on equity of -35.83. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Evogene Ltd. (NASDAQ: EVGN) Trading Performance Indicators
Let’s observe the current performance indicators for Evogene Ltd. (EVGN). The Stock has managed to achieve an average true range (ATR) of 0.32. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 129.48.
In the same vein, EVGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.82.
Technical Analysis of Evogene Ltd. (EVGN)
Through scrutinizing the latest numbers posted by the [Evogene Ltd., EVGN], it can be observed that its last 5-days Average volume of 1.21 million was better the volume of 0.37 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 65.28% While, its Average True Range was 0.34.
Raw Stochastic average of Evogene Ltd. (EVGN) in the period of the previous 100 days is set at 45.27%, which indicates a major fall in contrast to 56.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 126.81% that was lower than 129.10% volatility it exhibited in the past 100-days period.